PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2010 2012 2013 2014
This IM provides support to the Government of St Lucia to strengthen HIV laboratory services and strategic information, including systems for routine surveillance and M&E. This IM is national in scope and is in direct support of USG Caribbean Partnership Framework Goals for Strategic Information (Goal 2), and Laboratory Support (Goal 3). This IM also contributes directly to the development and strengthening of health systems and human resources. For laboratory support, this implementing mechanism supports training of both new and in-service laboratory personnel to cover key testing areas and quality systems essential components. It also supports the procurement of chemistry and haematology machines, ELISA test kits, HIV rapid test kits, and molecular testing including DNA PCR and viral load. For strategic information, this IM supports the implementation HIV/AIDS case surveillance, build the capacity of the MOH to conduct high quality bio-behavioral surveys of most-at-risk-populations (MARPS), and strengthen M&E systems. Funds under this IM will also support the planning, capacity strengthening, and implementation of MARP surveillance activities in Years 1, 2 and 3. CDC will continue to work in close collaboration with the MOH to ensure the efficient use of USG resources in achieving the programmatic priorities for the 5-year cooperative agreement. Starting in Year 1, the Ministry of Health developed a work plan with agreed-upon performance benchmarks. The MOH is also required to report on progress towards the essential and additional outcome indicators on a semi-annual and annual basis. The MOH is also developing a transition and sustainability plan for continuing activities beyond the 5-year cooperative agreement.
The Ministry of Health of St Lucia will utilize this cooperative agreement funds to support the capacity building of laboratory staff through regional and international trainings. Training workshop content areas will be: 1) TB diagnosis and EQA for AFB smear microscopy; 2) Good Clinical Laboratory practices (GCLP); 3) HIV rapid testing (including algorithm development, quality testing and use of logbooks); 4) and other areas of wet laboratory training.
Furthermore, selected laboratory staff from this country will attend international advanced trainings in CD4, clinical chemistry, hematology, Bio-safety and laboratory management as they prepare for accreditation.
These activities will greatly enhance and support the current cross cutting goal of training, capacity building and ensuring long term sustainability of in-country systems for testing, diagnosis, and patient monitoring.
The availability of high quality, reliable data remains a cross-cutting and overarching priority for the use of funds under the SI component. Moving forward in FY09, CDC will continue to support efforts undertaken by the Government of Saint Lucia to achieve results-based implementation of surveillance and M&E activities, with clear deliverables in Years 1, 2 and 3.
This Co-operative agreement will support ongoing collaborative efforts between the Ministry of Health and HHS/CDC Staff to improve national-level systems for strategic information, including the collection, analysis and use of data to better characterize the epidemic within the general population and among Most-At-Risk Populations. The Government of Saint Lucia will be requested to develop a sustainability plan as part of its Year 2 work plan, indicating how these activities will be sustained by the national government beyond the cooperative agreement.
Activities supported with FY08 funds will include support for revisions and refinements for the national protocol for HIV and TB Surveillance, and staff training in methods for HIV/AIDS case-based surveillance. The MOH will also finalize a review of its current HIV/AIDS dataset to address any gaps and improve the range of data being collected. Funding for FY08, 09, and 10 will also be utilized to support the development and implementation of behavioral surveys and special studies on MARPs, expanding the availability of behavioral surveillance data on selected MARP sub-groups, including MSM, CSW, and Drug Users.
CDC will work in close collaboration with the MOH to ensure progress towards the goals and objectives of the three-year Cooperative Agreement. Joint reviews, site visits, and observation of selected activities under the Co-Ag will be core components of a supportive supervision and quality assurance strategy for this implementing mechanism.
Indicator targets related to the HSVI budget code for this cooperative agreement include the existence of high quality surveillance and program monitoring reports for the preceding year, and the number of countries completing special studies.
This Cooperative Agreement makes a direct contribution to the development and strengthening of health systems and human resources in Saint Lucia. It adds strategic value in the delivery of laboratory services and integrates high quality HIV/AIDS data with the collection and reporting of surveillance and program monitoring data within the wider health sector.
